Last reviewed · How we verify
Flunarizine 5mg — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Flunarizine 5mg (Flunarizine 5mg) — Shalamar Institute of Health Sciences.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Flunarizine 5mg TARGET | Flunarizine 5mg | Shalamar Institute of Health Sciences | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Flunarizine 5mg CI watch — RSS
- Flunarizine 5mg CI watch — Atom
- Flunarizine 5mg CI watch — JSON
- Flunarizine 5mg alone — RSS
Cite this brief
Drug Landscape (2026). Flunarizine 5mg — Competitive Intelligence Brief. https://druglandscape.com/ci/flunarizine-5mg. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab